Home › Bids
› Assay Validation of High Quality Markers for Clinical Studie
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Open182 days leftHealthcaregrant
Oct 15, 2024
Oct 14, 2026 12:00 AM
Healthcare
grant
AI Summary
This grant opportunity (PAR-25-074, CFDA 93.394) seeks proposals for assay validation of high-quality markers for clinical studies in cancer. UH2/UH3 clinical trials are not allowed under this funding opportunity.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.